Fibrodysplasia Ossificans Progressiva - 7 Studies Found

Active, not recruiting : A Natural History Study of Fibrodysplasia Ossificans Progressiva (FOP)
: Fibrodysplasia Ossificans Progressiva
: 2014-12-08
Suspended : In-Home Evaluation of Episodic Administration of Palovarotene in Fibrodysplasia Ossificans Progressiva (FOP) Subjects
: Fibrodysplasia Ossificans Progressiva
: 2015-08-06
: Drug: Palovarotene Palovarotene will be taken orally once daily at approximately the same time each day.
Active, not recruiting : An Open-Label Extension Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
: Fibrodysplasia Ossificans Progressiva
: 2014-10-26
:
  • Drug: Palovarotene dose level 1

Active, not recruiting : An Efficacy and Safety Study of Palovarotene to Treat Preosseous Flare-ups in FOP Subjects
: Fibrodysplasia Ossificans Progressiva
: 2014-07-13
:
  • Drug: Palovarotene Palovaroten
Completed : Urine Sample Collection From FOP Patients
: Fibrodysplasia Ossificans Progressiva
: 2014-02-05
Active, not recruiting : An Open-Label Extension Study of Palovarotene to Prevent Heterotopic Ossification in FOP Subjects in France
: Fibrodysplasia Ossificans Progressiva
: 2016-11-23
:
  • Drug: Palovarotene dose level 1

COMPLETED : A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
: Fibrodysplasia Ossificans Progressiva (FOP)
: 2024-11-21
: No study treatment will be administered on this study.